ÇѾç´ëÇб³º´¿ø (¿Â¶óÀÎ) ³ú½Å°æ°èÁúȯ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2021-12-18±³À°ÀÏÀÚ : 2021-12-18
±³À°Àå¼Ò : (¿Â¶óÀÎ)ÇѾç´ëÇб³º´¿ø ¼°ü7Ãþ ¼¼Æ÷Ä¡·á¼¾ÅÍ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) ³ú½Å°æ°èÁúȯ¿¬±¸È¸ ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ÇѾç´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å°æ°ú
´ã´çÀÚ : ±èÇö±â
¿¬¶ôó : 02-2290-8378
À̸ÞÀÏ :
hyneurology@naver.com ±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 13:10~13:35 COVID-19 related neurologic problems ¿À¼ºÀÏ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 13:35~14:00 COVID-19 vaccination related neurologic disorders ¹èÁ¤ÈÆ(¼¿ïÀÇ´ë)
Åä·Ð 12-18 14:00~14:10 Q & A ()
ÈÞ½Ä 12-18 14:10~14:20 Coffee break ()
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 14:20~14:35 Recent Advances in treatment of AD ±èÈñÁø(ÇѾçÀÇ´ë)
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 14:35~14:50 Recent new treatment in PD Àå¿ì¿µ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 14:50~15:05 Recent treatment options in ALS/MND ÀÌ»ó°ï(ÇѾçÀÇ´ë)
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 15:05~15:20 Treatment of epilepsy with newly developed drugs ¹Ú¾ç¹Ì(¼¿ïÀÇ´ë)
Åä·Ð 12-18 15:20~15:30 Discussion / Q&A ()
ÈÞ½Ä 12-18 15:30~15:40 Coffee break ()
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 15:40~15:55 Management of antithrombotics before minor and major surgery ±ÇÇõ¼º(ÇѾçÀÇ´ë)
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 15:55~16:10 Polysomnography in practical use ¾çÇϸ°(¿ï»êÀÇ´ë)
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 16:10~16:25 New preventive treatment of Migraine ±èÇö¿µ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 12-18 ¼°ü7Ãþ¼¼Æ÷Ä¡·á¼¾ÅÍ 16:25~16:40 Management of intractable pain control ÀÌÇÏ´Ã(³ª´©¸®º´¿ø)
Åä·Ð 12-18 16:40~17:00 Discussion / Q&A ()